STARGAZER PHARMACEUTICALS, INC.

Profile

Company Names

STARGAZER PHARMACEUTICALS, INC.

Addresses

200 CLARENDON STREET, FLOOR 45, MAILBOX 30, BOSTON, MA 02215

Phone Numbers

5109138357

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$28,461,471.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-04-02 
$28,461,471.00 
$62,183,282.00 
$33,721,811.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
 
CURRAN 
DIRECTOR
POWERPOST, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  XILIO THERAPEUTICS, INC.
MARTIN 
 
EDWARDS 
DIRECTOR
LOGICAL THERAPEUTICS INC   |  TARSA THERAPEUTICS, INC.   |  COLUCID PHARMACEUTICALS, INC.   |  HARMONY BIOSCIENCES II, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  INOZYME PHARMA, INC.   |  VERONA PHARMA PLC   |  MORPHIC HOLDING, INC.
RICHARD 
 
GASTER 
DIRECTOR
ARRAKIS THERAPEUTICS, INC.   |  AEOVIAN PHARMACEUTICALS, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  ELEVATION ONCOLOGY, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  ATTRALUS, INC.   |  VENTYX BIOSCIENCES, INC.   |  ALUMIS INC.   |  ENTACT BIO, INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
WENDE 
 
HUTTON 
DIRECTOR
TRANSCEND MEDICAL INC   |  APIERON INC   |  CALIBRA MEDICAL, INC.   |  THERACLONE SCIENCES, INC.   |  REVISION OPTICS INC   |  ALTHEOS, INC.   |  ALDEA PHARMACEUTICALS, INC.   |  MATURE WOMEN-S HEALTH SOLUTIONS, INC.   |  DERMIRA, INC.   |  LABRYS BIOLOGICS, INC.   |  BUTTERFLY HEALTH, INC.   |  CHRONO THERAPEUTICS INC.   |  MINIMALLY INVASIVE DEVICES INC.   |  HERA THERAPEUTICS INC.   |  ONCORESPONSE INC   |  HYALEX ORTHOPAEDICS, INC.   |  QLARIS BIO, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  GLOOKO, INC.   |  ALCHERA INC   |  ANTIVA BIOSCIENCES, INC.   |  ONCORESPONSE, INC
NANNA 
 
LUNEBORG 
DIRECTOR
STARGAZER PHARMACEUTICALS, INC.   |  CAPSTAN THERAPEUTICS, INC.   |  MAPLIGHT THERAPEUTICS, INC.
IYONA 
 
RAJKOMAR 
DIRECTOR
STARGAZER PHARMACEUTICALS, INC.   |  ABCURO, INC.   |  ANTIOS THERAPEUTICS INC.
GARY 
 
STERNBERG 
EXECUTIVE OFFICER, DIRECTOR
STARGAZER PHARMACEUTICALS, INC.
JOHN 
 
WAGNER 
DIRECTOR
DYNETECH SECURED INCOME FUND, LLC   |  YIELD STRATEGIES FUND II LP   |  ENHANCED BOND FUND, LLC   |  CAMDEN BONDS PLUS FUND, LLC   |  CHAPMAN-S CIDER CO LLC   |  EQUITY OVERLAY FUND LLC   |  NUODB, INC.   |  APPLIED PROCESS HOLDINGS, LLC   |  SCW CAPITAL, LP   |  EVERQUOTE, INC.   |  NEOPHARM PHARMACANN INVESTORS II, LLC   |  CSC GOOSE NEST CAPITAL, LLC   |  STARGAZER PHARMACEUTICALS, INC.   |  COLABS HOLDINGS, LLC   |  SCW CAPITAL QP, LP   |  COLABS QOF, LLC   |  SCW SINGLE-ASSET PARTNERSHIP, LP   |  SCW SINGLE-ASSET PARTNERSHIP QP, LP   |  VCP D2 LP   |  VCP HL LP   |  VCP RL LP   |  VCP REFERWELL LP   |  D2 PHARMA CONSULTING LLC   |  CARE CONTINUITY, INC.   |  BENEFIT HARBOR, LP   |  VCP FOLLOW ON FUND, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-05-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-02 
2018-04-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#